How We’re Mobilizing Our Resources to Help Find Solutions for COVID-19
Learn More
Share
Global Disease Challenges
hile the world continues to face ongoing challenges with HIV and tuberculosis, and many unknown and emerging threats, there is also an increasing shift in burden of disease toward noncommunicable diseases (NCDs) and mental health. At Johnson & Johnson, we are passionate about our work to save and improve people’s lives. We forge partnerships and identify new ways to pioneer human ingenuity to accelerate the development of new drug regimens, support the strengthening of healthcare systems and break down barriers to access in resource-limited settings.
Our Aspiration: A world where innovations and holistic health solutions prevent, control and eliminate global disease challenges and epidemics.
5-Year Target: 175 million individuals will have benefited from Johnson & Johnson solutions that prevent, control and eliminate global diseases.
Status: Exceeded
Our Impact:
• How Johnson & Johnson Is Helping Tackle a Devastating Tropical Disease That Impacts Kids
• Working to Make HIV History
Related Content
Johnson & Johnson has signed up to the 2030 UN Sustainable Development Goals—the world’s road map for progress.
More From Johnson & Johnson
At the height of the outbreak in New York City, Dr. Ed Kuffner took a leave of absence from his job to volunteer at a Brooklyn hospital hard hit by the pandemic. He shares what the experience taught him about his own strengths—and ideas for coping during this unprecedented time.
Johnson & Johnson's Chief Communication Officer Michael Sneed sits down to have a frank discussion about what we need to do to help build a more equitable healthcare system—and society.
JOHNSON’S® Baby Powder, made from cosmetic talc, has been a staple of baby care rituals and adult skin care and makeup routines worldwide for over a century.
